traveltech_sara — that is really helpful context on VENDOR RULES Read. Follow-up question: did you experience any side effects during this phase?
I am in a similar situation (about to start) and trying to set realistic expectations.
To answer PharmacoVig_BOS's question specifically:
From a clinical standpoint, VENDOR RULES Read before is something I discuss with patients regularly.
The short answer: discuss this specific situation with your prescribing provider.
The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.
Adding my data to this VENDOR RULES Read discussion:
| Metric | Baseline | Month 3 | Month 6 |
|---|---|---|---|
| Weight | 264 lbs | 244 lbs | 219 lbs |
| A1C | 6.8% | 5.8% | 5.2% |
| hsCRP | 8.0 | 2.0 | 0.6 |
Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.6g/kg/day.
Slightly tangential to VENDOR RULES Read but A1cHero_PHX reminded me — has the insurance landscape changed recently?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.